Literature DB >> 7725726

Intravenous immune globulin.

E P Gabor.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 7725726      PMCID： PMC1022730     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  8 in total

1.  Aseptic meningitis associated with high dose intravenous immunoglobulin therapy.

Authors:  J D Watson; J Gibson; D E Joshua; H Kronenberg
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-03       Impact factor: 10.154

2.  Treatment of systemic vasculitis with pooled intravenous immunoglobulin.

Authors:  D R Jayne; M J Davies; C J Fox; C M Black; C M Lockwood
Journal:  Lancet       Date:  1991-05-11       Impact factor: 79.321

3.  Intravenous immune globulin and acute aseptic meningitis.

Authors:  M Casteels-Van Daele; L Wijndaele; K Hanninck; P Gillis
Journal:  N Engl J Med       Date:  1990-08-30       Impact factor: 91.245

4.  Reversal of chronic polymyositis following intravenous immune serum globulin therapy.

Authors:  C M Roifman; F M Schaffer; S E Wachsmuth; G Murphy; E W Gelfand
Journal:  JAMA       Date:  1987 Jul 24-31       Impact factor: 56.272

5.  Recurrent migraine and intravenous immune globulin therapy.

Authors:  C S Constantinescu; A P Chang; L F McCluskey
Journal:  N Engl J Med       Date:  1993-08-19       Impact factor: 91.245

6.  Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: an open study with 20 adult patients.

Authors:  P Cherin; S Herson; B Wechsler; J C Piette; O Bletry; A Coutellier; J M Ziza; P Godeau
Journal:  Am J Med       Date:  1991-08       Impact factor: 4.965

Review 7.  The use and mechanism of action of intravenous immunoglobulin in the treatment of immune haematologic disease.

Authors:  J B Bussel; M W Hilgartner
Journal:  Br J Haematol       Date:  1984-01       Impact factor: 6.998

8.  A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis.

Authors:  M C Dalakas; I Illa; J M Dambrosia; S A Soueidan; D P Stein; C Otero; S T Dinsmore; S McCrosky
Journal:  N Engl J Med       Date:  1993-12-30       Impact factor: 91.245
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.